Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 12Pain, Postoperative 11Pain 11Breast Neoplasms 9Agnosia 9Depression 8Head and Neck Neoplasms 6Chronic Pain 4Anxiety Disorders 4Pancreatic Neoplasms 3Pain, Intractable 3Colorectal Neoplasms 3Acute Pain 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mucositis 2Gastrointestinal Neoplasms 2Cancer Pain 2Stomatitis 1Spinal Stenosis 1Rectal Neoplasms 1Postoperative Analgesia 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Pain, Procedural 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Laparoscopic Colorectal Resection Due to Cancer 1

Interventions

Saline Solution 1Midazolam 1Meperidine 1Ketamine 1Cefoxitin 1Blood Specimen Collection 1Antibiotic Prophylaxis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholangitis × Ketamine × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡